$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

Galectin Therapeutics Inc Unit Cons of 2 shs + 1 Wt
(NASDAQ : GALTU)

( )
GALTU After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading GALTU News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
-0.52%80.081.6%$832.49m
BIIBBiogen Inc.
-0.80%306.851.2%$597.13m
AMGNAmgen Inc.
-0.36%170.231.0%$511.98m
CELGCelgene Corporation
-2.43%107.910.8%$482.97m
MDVNMedivation, Inc.
0.01%80.241.8%$432.24m
REGNRegeneron Pharmaceuticals, Inc.
-1.23%400.253.4%$315.21m
ILMNIllumina, Inc.
-0.04%169.484.4%$230.36m
BMRNBioMarin Pharmaceutical Inc.
-0.17%94.973.6%$200.85m
ALXNAlexion Pharmaceuticals, Inc.
-2.23%129.172.6%$192.32m
VRTXVertex Pharmaceuticals Incorporated
-0.34%96.382.3%$118.00m
INCYIncyte Corporation
-2.84%80.102.6%$104.35m
IONSIonis Pharmaceuticals, Inc.
-4.01%30.3711.1%$94.18m
AAgilent Technologies, Inc.
1.18%47.250.9%$93.53m
EXASExact Sciences Corporation
0.42%19.0530.9%$93.32m
TSROTESARO, Inc.
-2.16%85.2315.8%$87.59m

Company Profile

Galectin Therapeutics, Inc. operates as a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease and cancer. Its drug candidates are based on the method of targeting galectin proteins, which are key mediators of biologic and pathologic function and its focus is on diseases with serious, life-threatening consequences to patients and those where current treatment options are limited. The company was founded by James C. Czirr and Anatole A. Kltyosov on July 10, 2000 and is headquartered in Norcross, GA.